Suppr超能文献

过去17年中无冠状动脉疾病病史的经皮冠状动脉介入治疗患者的Framingham风险评分及心血管危险因素患病率的时间趋势分析:来自梅奥诊所PCI登记处的一项研究

Time-trend analysis on the Framingham risk score and prevalence of cardiovascular risk factors in patients undergoing percutaneous coronary intervention without prior history of coronary vascular disease over the last 17 years: a study from the Mayo Clinic PCI registry.

作者信息

Lee Moo-Sik, Flammer Andreas J, Li Jing, Lennon Ryan J, Singh Mandeep, Holmes David R, Rihal Charanjit S, Lerman Amir

机构信息

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; Department of Preventive Medicine, College of Medicine, Konyang University, Daejeon, South Korea.

出版信息

Clin Cardiol. 2014 Jul;37(7):408-16. doi: 10.1002/clc.22274. Epub 2014 Mar 20.

Abstract

BACKGROUND

There is a paucity of data on the temporal trends of cardiovascular risk factors in patients undergoing percutaneous coronary intervention (PCI). We investigated the secular trends of risk profiles of patients undergoing PCI without prior history of cardiovascular disease (CVD).

HYPOTHESIS

CVD risk factors are changed over time.

METHODS

This time-trend analysis from 1994 to 2010 was performed within the Mayo Clinic PCI Registry. Outcome measures were prevalence of CVD risk factors, including the Framingham risk score (FRS), at the time of admission for PCI.

RESULTS

During this period, 12,055 patients without a history of CVD (mean age, 65.0 ± 12.4 years, 67% male) underwent PCI at the Mayo Clinic. Age distribution slightly shifted toward older age (P for trend <0.05), but sex did not change over time. Despite a higher prevalence of hypertension, hypercholesterolemia, and diabetes mellitus over time, actual blood pressure and lipid profiles improved (P for trend <0.001). Over time, FRS and 10-year CVD risk improved significantly (7.3 ± 3.2 to 6.5 ± 3.3, P for trend <0.001; and 11.0 to 9.0, P for trend <0.001, respectively). Body mass index, not included in the FRS, increased significantly (29.0 ± 5.2 to 30.1 ± 6.2 kg/m(2) , P for trend <0.001), whereas smoking prevalence did not change.

CONCLUSIONS

The current study demonstrates that although traditional FRS and its associated predicted 10-year cardiovascular risk declined over time, the prevalence of risk factors increased in patients undergoing PCI. The study suggests the need for a new risk-factor assessment in this patient population.

摘要

背景

关于接受经皮冠状动脉介入治疗(PCI)患者心血管危险因素的时间趋势数据匮乏。我们调查了无心血管疾病(CVD)既往史的PCI患者风险概况的长期趋势。

假设

CVD危险因素随时间变化。

方法

在梅奥诊所PCI注册研究中进行了这项1994年至2010年的时间趋势分析。观察指标为PCI入院时CVD危险因素的患病率,包括弗雷明汉风险评分(FRS)。

结果

在此期间,12,055例无CVD病史的患者(平均年龄65.0±12.4岁,67%为男性)在梅奥诊所接受了PCI。年龄分布略微向老年偏移(趋势P<0.05),但性别未随时间变化。尽管高血压、高胆固醇血症和糖尿病的患病率随时间升高,但实际血压和血脂状况有所改善(趋势P<0.001)。随着时间推移,FRS和10年CVD风险显著改善(分别从7.3±3.2降至6.5±3.3,趋势P<0.001;从11.0降至9.0,趋势P<0.001)。FRS未纳入的体重指数显著升高(从29.0±5.2增至30.1±6.2kg/m²,趋势P<0.001),而吸烟患病率未变。

结论

当前研究表明,尽管传统FRS及其相关的预测10年心血管风险随时间下降,但接受PCI患者的危险因素患病率升高。该研究提示在这一患者群体中需要进行新的危险因素评估。

相似文献

7
Trends in cardiovascular risk factors among people with diabetes in a population based study, Health Survey for England 1994-2009.
Prim Care Diabetes. 2013 Oct;7(3):193-8. doi: 10.1016/j.pcd.2013.04.010. Epub 2013 May 16.
8
Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
Int J Clin Pharm. 2020 Dec;42(6):1469-1479. doi: 10.1007/s11096-020-01112-2. Epub 2020 Sep 22.
10
The prevalence of risk factors for cardiovascular diseases among Polish surgical patients over 65 years.
Clin Interv Aging. 2016 May 13;11:631-9. doi: 10.2147/CIA.S105201. eCollection 2016.

引用本文的文献

3
Association of metabolic risks with subclinical hypothyroidism: A cross-sectional analysis.
Pak J Med Sci. 2018 Mar-Apr;34(2):357-362. doi: 10.12669/pjms.342.13873.
7
Association of traditional risk factors with coronary artery disease in nonagenarians: the primary role of hypertension.
Clin Interv Aging. 2014 Nov 20;9:2003-12. doi: 10.2147/CIA.S74471. eCollection 2014.

本文引用的文献

2
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.
Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15.
5
Current place of beta-blockers in the treatment of hypertension.
Curr Vasc Pharmacol. 2010 Nov;8(6):733-41. doi: 10.2174/157016110793563861.
6
Angiotensin receptor blockers for management of hypertension.
South Med J. 2010 Jul;103(7):669-73. doi: 10.1097/SMJ.0b013e3181e1e2da.
7
Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events.
Eur Heart J. 2010 May;31(9):1142-8. doi: 10.1093/eurheartj/ehq010. Epub 2010 Feb 24.
8
JNC 8: expectations, challenges, and wishes--a primary care perspective.
J Clin Hypertens (Greenwich). 2009 Oct;11(10):573-6. doi: 10.1111/j.1751-7176.2009.00157.x.
9
Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study.
Circulation. 2009 Jul 21;120(3):212-20. doi: 10.1161/CIRCULATIONAHA.108.846519. Epub 2009 Jul 6.
10
Adverse consequences of the 50% misconception.
Am J Cardiol. 2009 Feb 1;103(3):426-7. doi: 10.1016/j.amjcard.2008.09.098. Epub 2008 Nov 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验